Concepedia

Khosrow Kashfi

KK

Statistics

Publications

70

Citations

3.2K

H-Index

35

Active since

1990

Affiliations

City University of New York(Current)

New York Medical College

Shahid Beheshti University of Medical Sciences

Research Institute for Endocrine Sciences

New York Institute of Technology

Khosrow Kashfi is an author at City University of New York specializing in pharmacology, medicine, and oxidative stress.

ORCID

Top concepts

Publications per year

1990–2023

70

Publications

70

NOSH-Aspirin: A Novel Nitric Oxide–Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals

Ravinder Kodela, Mitali Chattopadhyay, Khosrow Kashfi · ACS Medicinal Chemistry Letters · 2012 · 173 citations

, , +15

Nitric Oxide-Donating Nonsteroidal Anti-Inflammatory Drugs Inhibit the Growth of Various Cultured Human Cancer Cells: Evidence of a Tissue Type-Independent Effect

Khosrow Kashfi, Yaser Rayyan, Leon L. Qiao et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 132 citations

The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells

Cristiana Bortuzzo, Rashid Hanif, Khosrow Kashfi et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1996 · 130 citations · Full text

Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: A general property and evidence of a tissue type-independent effect

Mitali Chattopadhyay, Ravinder Kodela, Niharika Nath et al. · Biochemical Pharmacology · 2011 · 129 citations

, , +8

NOSH–aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model

Mitali Chattopadhyay, Ravinder Kodela, Kenneth R. Olson et al. · Biochemical and Biophysical Research Communications · 2012 · 127 citations

, , +8

1–5 of 70